- Nachrichtendetail
-
12.03.2024 11:02:26 - dpa-AFX: *IDEAYA BIOSCIENCES ENTERS CLINICAL TRIAL COLLABORATION WITH MERCK TO EVALUATE IDE161 WITH KEYTRUDA IN ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 131,200 | 26.04.24 03:00:26 | +0,480 | +0,37% | 130,730 | 132,000 | 130,130 | 131,200 |
